Suicidal clinical trials

Explore recruiting suicidal clinical trials.

Recruiting suicidal studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Suicidal trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Nitrous Oxide in Resistant Depression in Elderly Subjects: A Randomized, Double-blind, Comparator Trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Traitement des Idées Suicidaires aux urgences par adjonction de Protoxyde d’Azote (PROTORISC pilote)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Add-on buprenorphine at analgesic doses for the treatment of severe suicidal ideas during a major depressive episode

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania with Mixed Features in Bipolar-I Disorder (BALSAM-3)

Hungary, Romania, Poland, Sweden, Croatia, Spain +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational study

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of KarXT in Adolescents (13 to 17 years of age) with Schizophrenia and KarXT+KarX-EC in Children and Adolescents (5 to 17 years of age) with Irritability Associated with Autism Spectrum Disorder

Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Suicidal trials by city

Suicidal in Toronto Suicidal in Vancouver Suicidal in Montreal Suicidal in Calgary Suicidal in Edmonton Suicidal in Ottawa Suicidal in Winnipeg Suicidal in Quebec City Suicidal in Hamilton Suicidal in Kitchener Suicidal in London Suicidal in Halifax Suicidal in New York Suicidal in Los Angeles Suicidal in Chicago Suicidal in Houston

Suicidal clinical trials

Recruiting suicidal studies right now

Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents

Development and Testing of imHere4U: A Digital Suicide Prevention Intervention for Cyberbullied Adolescents

Flourish in Schools Pilot Study

Assessment of Emotion Regulation Strategies Used When Suicidal

SHame prOpensity in bOrderline Personality Disorder

Music Against Psychological Pain in Suicide

Efficacy of the I-CARE Digital Health Intervention

The BEAR Program for Women With Trauma Who Have Suicidal Thoughts

Blended Unified Protocol in Chinese Adolescents With Non-Suicidal Self-Injury

Social Threat, Adolescent Relationships, and Suicidality Study

Stepped Approach to Reducing Risk of Suicide in Primary Care

iFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)

Also recruiting in Europe

Nitrous Oxide in Resistant Depression in Elderly Subjects: A Randomized, Double-blind, Comparator Trial

Traitement des Idées Suicidaires aux urgences par adjonction de Protoxyde d’Azote (PROTORISC pilote)

Add-on buprenorphine at analgesic doses for the treatment of severe suicidal ideas during a major depressive episode

A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania with Mixed Features in Bipolar-I Disorder (BALSAM-3)

The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational study

A Phase 3 Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of KarXT in Adolescents (13 to 17 years of age) with Schizophrenia and KarXT+KarX-EC in Children and Adolescents (5 to 17 years of age) with Irritability Associated with Autism Spectrum Disorder

Suicidal trials by city

Other conditions